Clinicopathologic features, concurrent genomic alterations, and clinical outcomes of patients with KRAS G12D mutations in resected lung adenocarcinoma

In light of the ongoing clinical development of KRAS G12D-specific inhibitors, we sought to investigate the clinicopathologic, co-occurring genomic features and outcomes of patients with KRAS G12D-mutant lung adenocarcinoma.

Source: European Journal of Cancer - March 1, 2024 Category: Cancer & Oncology Authors: Hang Cao, Zelin Ma, Qingyuan Huang, Han Han, Yuan Li, Yang Zhang, Haiquan Chen Tags: Original Research Source Type: research